F Salmerón, P Pérez Breña, J M Rojas, R Hernáez Lobo, E Tabarés
{"title":"Evaluation of three methods for typing herpes simplex virus.","authors":"F Salmerón, P Pérez Breña, J M Rojas, R Hernáez Lobo, E Tabarés","doi":"10.1007/BF02013066","DOIUrl":null,"url":null,"abstract":"<p><p>Three methods of typing herpes simplex virus were compared. A total of 111 clinical isolates obtained from patients not treated with antivirals and seven resistant mutants selected in vitro were tested by immunofluorescence assay using antibodies against herpes simplex virus types 1 and 2. Twenty-nine isolates were also studied by restriction endonuclease analysis. The sensitivity of isolates and resistant mutants to (E)-5-(2-bromovinyl)-2'-deoxyuridine was determined. Although a clear difference between the 50% inhibitory dose for type 1 and type 2 isolates was observed, some drug-resistant mutants might be misidentified by this method.</p>","PeriodicalId":11958,"journal":{"name":"European Journal of Clinical Microbiology","volume":"6 6","pages":"664-7"},"PeriodicalIF":0.0000,"publicationDate":"1987-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF02013066","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"European Journal of Clinical Microbiology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/BF02013066","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Three methods of typing herpes simplex virus were compared. A total of 111 clinical isolates obtained from patients not treated with antivirals and seven resistant mutants selected in vitro were tested by immunofluorescence assay using antibodies against herpes simplex virus types 1 and 2. Twenty-nine isolates were also studied by restriction endonuclease analysis. The sensitivity of isolates and resistant mutants to (E)-5-(2-bromovinyl)-2'-deoxyuridine was determined. Although a clear difference between the 50% inhibitory dose for type 1 and type 2 isolates was observed, some drug-resistant mutants might be misidentified by this method.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
